Selected article for: "present study and SARS infection"

Author: Lin Fu; Jun Fei; Shen Xu; Hui-Xian Xiang; Ying Xiang; Zhu-Xia Tan; Meng-Die Li; Fang-Fang Liu; Ying Li; Ming-Feng Han; Xiu-Yong Li; Hui Zhao; De-Xiang Xu
Title: Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort study
  • Document date: 2020_4_6
  • ID: 5gbjdr0u_28
    Snippet: The present study aimed to analyze SARS-CoV-2-induced ALI, its association with death risk and the prognosis after discharge. The major findings of this study include: (1) ALI is more common in the critically ill COVID-19 patients; (2) Accumulating data demonstrated that SARS-CoV-2 infection caused multiple organ injuries, including myocardial dysfunction, lymphopenia and even acute renal These results provide evidence that ALI on admission is as.....
    Document: The present study aimed to analyze SARS-CoV-2-induced ALI, its association with death risk and the prognosis after discharge. The major findings of this study include: (1) ALI is more common in the critically ill COVID-19 patients; (2) Accumulating data demonstrated that SARS-CoV-2 infection caused multiple organ injuries, including myocardial dysfunction, lymphopenia and even acute renal These results provide evidence that ALI on admission is associated with the severity of COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • acute lymphopenia myocardial dysfunction and present study: 1
    • acute lymphopenia myocardial dysfunction and SARS infection: 1
    • critically ill patient and death risk: 1
    • critically ill patient and myocardial dysfunction: 1, 2, 3
    • critically ill patient and organ injury: 1, 2
    • critically ill patient and patient severity: 1
    • critically ill patient and present study: 1, 2, 3
    • critically ill patient and renal result: 1
    • critically ill patient and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • death risk and discharge prognosis: 1, 2, 3
    • death risk and discharge prognosis death risk association: 1, 2
    • death risk and multiple organ injury: 1
    • death risk and myocardial dysfunction: 1, 2, 3
    • death risk and organ injury: 1, 2, 3, 4, 5, 6, 7
    • death risk and patient severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • death risk and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
    • death risk and renal result: 1, 2, 3
    • death risk and SARS analyze: 1, 2, 3
    • death risk and SARS analyze aim: 1